Ad
related to: sickle cell disease foundation- Mechanism Of Action
Learn About The LYFGENIA
MOA & How It Works.
- Treatment Pathway
Get An Overview Of The Treatment
Steps With LYFGENIA.
- Request A Representative
Fill Out The Online Form To Be
Contacted About LYFGENIA.
- Support & Resources
Support For Your Patients During
Their Consideration & Treatment.
- FAQs
Get Answers To Questions
About Treatment With LYFGENIA.
- Find A QTC
Use The Qualified Treatment Center
Locator To Find One Nearest You.
- Mechanism Of Action
Search results
Results From The WOW.Com Content Network
Felix Israel Domeno Konotey-Ahulu FGA, FRCPSG, FRCP, FWACP (born 12 July 1930) is a Ghanaian physician and scientist who is Kwegyir Aggrey Distinguished Professor of Human Genetics at the University of Cape Coast, Ghana, and a consultant physician/genetic counsellor, Haemoglobinopathy/Sickle Cell States, in Harley Street, London. [4]
The sickle cell trait provides a survival advantage against malaria fatality over people with normal hemoglobin in regions where malaria is endemic. The trait is known to cause significantly fewer deaths due to malaria, especially when Plasmodium falciparum is the causative organism.
As part of his work with the Center, Ohene-Frempong led the Cooperative Study of Sickle Cell Disease (CSSCD), [1] a multicenter study with the purpose of "[determining] the natural history of sickle cell disease from birth to death in order to identify those factors contributing to the morbidity and mortality of the disease."
Sampat Tukaram Ramteke (Aug 1949 - Nov 2017) was an engineer and social activist from Nagpur, Maharashtra, India.In 2018, he was conferred the Padma Shri civilian honour posthumously, for his contribution in raising awareness in India about the sickle cell disease.
Proliferative sickle retinopathy is the most severe ocular complication of sickle cell disease. Even though PSCR begins in the first decade of life, the condition remains asymptomatic and unnoticed until visual symptoms occur due to vitreous hemorrhage or retinal detachment.
Sickle cell nephropathy is a type of kidney disease associated with sickle cell disease which causes kidney complications as a result of sickling of red blood cells in the small blood vessels. The hypertonic and relatively hypoxic environment of the renal medulla , coupled with the slow blood flow in the vasa recta , favors sickling of red ...
Established as a locally registered charity in 1986, the Trust assisted in the development of research and sickle-cell services. The acquisition of a diagnostic ultrasound instrument was followed by construction of a dedicated Sickle Cell Clinic in 1988 and an Education Centre for Sickle Cell Disease in 1994.
Indications for red blood cell transfusion. Transfusion therapy for sickle-cell disease entails the use of red blood cell transfusions in the management of acute cases of sickle cell disease and as a prophylaxis to prevent complications by decreasing the number of red blood cells (RBC) that can sickle by adding normal red blood cells.